I am a molecular and clinical epidemiologist with a focus on cancer epidemiology and a background as a board-certified internal medicine physician. My main research interest is how potentially modifiable exposures cause solid tumors through genomic heterogeneity and influence cancer progression. I am passionate about combining well-defined observational studies and state-of-the-art genomics in order to guide cancer prevention and treatment. My methodologic and teaching interests include application and further development of epidemiologic methods for high-dimensional biomarker studies and clinical studies.
In my highly interdisciplinary research program, I bring together and lead teams across epidemiology, genomics, pathology, bioinformatics, clinical medicine, and preclinical research. My research has been funded by a Prostate Cancer Foundation Young Investigator Award, a Department of Defense Early-Investigator Research Award, and several other third-party grants.